27,280 Shares of Prestige Consumer Healthcare Inc. $PBH Purchased by Milestone Asset Management LLC

Milestone Asset Management LLC acquired a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the 3rd quarter, HoldingsChannel.com reports. The fund acquired 27,280 shares of the company’s stock, valued at approximately $1,251,000.

Other large investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in Prestige Consumer Healthcare during the second quarter worth about $370,187,000. Rice Hall James & Associates LLC acquired a new stake in shares of Prestige Consumer Healthcare during the second quarter valued at about $32,602,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Prestige Consumer Healthcare during the second quarter valued at about $31,135,000. Bank of America Corp DE purchased a new stake in shares of Prestige Consumer Healthcare in the 2nd quarter valued at approximately $26,277,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Prestige Consumer Healthcare in the 2nd quarter valued at approximately $15,376,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on PBH. Zacks Research upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “strong-buy” rating in a report on Wednesday, September 30th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 22nd. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $67.67.

Prestige Consumer Healthcare Trading Up 1.6%

PBH opened at $49.19 on Friday. Prestige Consumer Healthcare Inc. has a 52 week low of $42.62 and a 52 week high of $71.07. The company has a quick ratio of 1.99, a current ratio of 3.23 and a debt-to-equity ratio of 1.06. The business has a fifty day simple moving average of $49.26 and a 200-day simple moving average of $50.38. The firm has a market cap of $2.33 billion, a P/E ratio of 13.78, a P/E/G ratio of 1.52 and a beta of 0.34.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.09. The firm had revenue of $265.71 million for the quarter, compared to the consensus estimate of $253.02 million. Prestige Consumer Healthcare had a return on equity of 11.39% and a net margin of 15.57%. The company’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.90 EPS. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. On average, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.56 earnings per share for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc (NYSE: PBH) is a consumer healthcare company that develops, markets and distributes over-the-counter (OTC) products and household health-care brands. Its portfolio includes products for eye care, oral care, gastrointestinal health, pain relief, respiratory health, women’s health, and other everyday health needs.

The company’s brands include Dramamine, Bonine, BC, Goody’s, Clear Eyes, TheraTears, Monistat, Summer’s Eve, Vagisil, Luden’s, Chloraseptic, Compound W, Fleet and Debrox.